In an interview on the platform for high-tech startups Venturelab, Peter confirms something that we were already starting to presume in Hemex; Scailyte is developing rapidly. “However, the learning curve has been and still is extremely steep – as the start-up develops rapidly, so do I, and that is really exciting”. As a founder and […]
Investment Press Release
hemotune makes a significant step forward: advancing into clinical trials after completing CHF 14 million Series B2 round
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Diversity Hemex Team
We welcome David to the team!
HEMEX contribution for preparing tomorrow's leaders!
Continue reading
Investment Press Release
Driving the future of non-surgical endometriosis diagnosis: Hera Biotech acquires Scailyte’s endometriosis diagnostic assets
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Hemex Team
Graphic Design Internship at HEMEX
Noémie is a student at FMS Muttenz. She completed a two-week internship at HEMEX focusing [...]
Continue reading
Hemex Team Press Release
HEMEX opens subsidiary in Belgium, expanding its presence in the EU
Liestal, Switzerland, September 2023 – HEMEX, a bench-to-market clinical Contract Research Organization (CRO) announces the [...]
Continue reading
Congratulations to our portfolio company Scailyte for being selected among the 12 finalists for the Nature Research Spinoff Prize. The Spinoff Prize is a new Nature Research Award for early-stage university spinoff companies from around the world. The Award has been established by Nature Research in partnership with Merck to showcase and celebrate global excellence in […]
Numerous Swiss and European start-ups and SME’s applied for this year’s Swiss Innovation Challenge! In the 1st pitching round, 100 innovative participants presented their projects in front of a competent jury. Selected start-ups also benefit from a comprehensive support platform with individual coaching, tailored education, and mentoring, as well as get access to potential investors […]
The new GeoHealthApp enables users in Germany and Switzerland to determine their individual infection risk for COVID-19, thus making a pivotal contribution to reduce the spread of SARS-CoV2. Through a traffic light system on their smartphone display, users receive information about individualized current infection risks. The information results from the frequented locations of the past […]
2020 Swiss Innovation Challenge – the traditional networking kick-off event for the SIC was held virtually due to COVID-19 crisis on April 2, 2020! Numerous entrepreneurs from Switzerland and other European countries attended the online kick-off for this years challenge. 100 start-ups from all categories will be admitted to the first pitch, but only 50 […]
Inura Medical AG is admitted to participate at the 2020 >>venture>> competition! Inura Medical AG is a Swiss start-up company focused on the development of re-purposed urological products that combine a medical technology consisting of an urethral suppository and a pharmaceutical agent. Its first product offers a rescue therapy to two highly prevalent and disabling […]
Funding, Innovation
Scailyte announces its new advisory board composed of world leading clinicians and scientists
Scailyte™ is an ETH Zürich Spin-off and Top100 Swiss Startup applying artificial intelligence to discover novel and ultra-sensitive biomarkers from single-cell data.Over the past 3 years, we have established ScaiVision™, a proprietary data analytics platform for clinical research, which enables us to achieve groundbreaking discoveries in multiple disease areas. We have validated our approach by […]
- 1
- 2